Pure Global
NCT06377592

Development and Accuracy Evaluation of Gram Staining Analysis AI

GramEye·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bacterial Infections
Drug/Device/Intervention
Sample collection without intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
GramEye
Location
Suita, Japan
Timeline & enrollment
Phase
N/A
Start date
May 10, 2023
End date
Mar 31, 2027
Enrollment
18000 participants
Primary outcome

Advanced level of blood culture Gram stain analysis AI accuracy,Ordinary level of blood culture Gram stain analysis AI accuracy

Summary

The investigators use Gram-stained specimens provided from clinical settings to develop and
 evaluate the accuracy of Gram staining analysis AI

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsOther bacterial intestinal infectionsOther bacterial diseasesOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06377592
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06377592 through Pure Global AI's free database. This phase not specified trial is sponsored by GramEye and is currently Recruiting. The study focuses on Bacterial Infections. Target enrollment is 18000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.